Natural Capsules Ltd Share Price

55.00

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 21-Dec-2019 - -
Outcome of Board Meeting held on 21st December, 2019 pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015: In accordance with Regulation 30, read with Schedule III, Part A, Para B, Clause 2 & 5 of SEBI (Listing Obligations & Disclosure Requirements)Regulations, 2015 and Annexure 1 of SEBI circular CIR/CFD/CMD/4/2015 dated September, 9 2015, we wish to inform you that the Board of Directors at their meeting held today i.e. 21.12.2019, have approved Companys proposal to acquire new business. Natural capsules to acquire API business of Naari Pharma Private Limited Strategic Rationale for Diversification:
Board Meeting - 04-Nov-2019 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve 1. To consider and approve unaudited Standalone financial and unaudited consolidated financial results of the Company for the Quarter and Half Year ended September 30th 2019. 2. To consider and approve the appointment of Mrs. Shilpa Burman as Company Secretary and Compliance Officer of the company and to accept the resignation of Mr. Skandan P Jain from the post of Company Secretary and Compliance officer of the Company. Sub: Outcome of Board Meeting held on 12th November 2019 pursuant to Regulation 30 , 33(1)(d) of SEBI (LODR) Regulations, 2015: Board of Directors at their meeting held on 12.11.2019, inter alia has transacted the following: 1.Un-Audited Standalone Financials and Un-Audited Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2019 along with limited review report issued by the Statutory Auditors. 2.Appointment of Mr. C P Rangachar as the Chairman of the Company. 3.Resignation of Mr. Skandan Prakash Jain as the Company Secretary & Compliance Officer of the Company, due to some personal reasons with immediate effect. 4.Appointment of Mrs. Shilpa Burman as the Company Secretary & Compliance Officer of the Company. 5.The Board Meeting Commenced at 3.00 PM & Concluded at 6.35PM (As Per BSE Announcement Dated 12.11.2019)
Board Meeting - 18-Jul-2019 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve Sub: Board Meeting We wish to inform you that 129th meeting of the Board of Directors of the company is scheduled to be held on Friday, 09th Aug 2019, inter alia to consider the following: 1. To consider and approve unaudited financial results of the Company for the Quarter ended June 30th, 2019. Pursuant to and in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the policy/ code of internal procedures and conduct for regulating, monitoring and reporting of trading by insiders of the Company, the trading window for the Directors and specified employees is already closed and it shall remain closed till the conclusion of 48 hours after the declaration of financial results of the Company. Outcome of Board Meeting Held on 09th Aug 2019 (As Per BSE Announcement Dated 09.08.2019)
Board Meeting - 22-May-2019 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve the Consolidated Audited Financial Results of the Company for the Financial Year ended March 31st March 2019 and also to consider and if thought fit, to recommend dividend for the F.Y 2018-19. 30th May 2019 Bengaluru M/s. Bombay Stock Exchange Limited Corporate Services, 25th Floor, P.J.Towers, Mumbai - 400 001. India. Security Code: 524654 Sir, Sub: Outcome of Board Meeting held on 30th May 2019: Board of Directors at their meeting held on 30.05.19, inter alia has transacted the following: 1. Adoption of Standalone & Consolidated Audited Financial Results for the Year Ended 31st March 2019. 2. The Board of Directors has recommended Final Dividend of 10% each on equity shares of Rs.10 each, subject to approval of Shareholders in the forthcoming 26th Annual General Meeting. 3. Appointment of Mr. Pramod Kasat as Independent Non-Executive Director. 4. Reconstitution of Committees of the Board in line with amended SEBI, (LODR) Regulations 2015. 5. Adoption of New Policies in line with amended SEBI, (LODR) Regulations 2015. Further, The Statutory Auditors have issued Unmodified Audit Report for the F.Y 31.03.2019. Kindly take the above information on records. Thank You, For Natural Capsules Limited. Skandan.P.Jain Company Secretary and Compliance Officer. 30th May 2019 Bengaluru M/s. Bombay Stock Exchange Limited Corporate Services, 25th Floor, P.J.Towers, Mumbai - 400 001. India. Security Code: 524654 Sir, Sub: Outcome of Board Meeting held on 30th May 2019: Board of Directors at their meeting held on 30.05.19, inter alia has transacted the following: 1. Adoption of Standalone & Consolidated Audited Financial Results for the Year Ended 31st March 2019. 2. The Board of Directors has recommended Final Dividend of 10% each on equity shares of Rs.10 each, subject to approval of Shareholders in the forthcoming 26th Annual General Meeting. 3. Appointment of Mr. Pramod Kasat as Independent Non-Executive Director. 4. Reconstitution of Committees of the Board in line with amended SEBI, (LODR) Regulations 2015. 5. Adoption of New Policies in line with amended SEBI, (LODR) Regulations 2015. Further, The Statutory Auditors have issued Unmodified Audit Report for the F.Y 31.03.2019. Kindly take the above information on records. Thank You, For Natural Capsules Limited. Skandan.P.Jain Company Secretary and Compliance Officer. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 04-Feb-2019 - -
Quarterly Results NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2019 ,inter alia, to consider and approve We wish to inform you that 127th meeting of the Board of Directors of the company is scheduled to be held on Saturday, 09th Feb, 2019, inter alia to consider the following: 1. To consider and approve unaudited financial results of the Company for the Quarter ended Dec 31st 2018. Pursuant to and in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the policy/ code of internal procedures and conduct for regulating, monitoring and reporting of trading by insiders of the Company, the trading window for the Directors and specified employees would be closed from 2nd Feb 2019 to 11th Feb 2019. This closure is occasioned by reason of the meeting of the Board of Directors of the Company, which is scheduled to be held on 09th Feb, 2019 the trading window for the Directors and specified employees would be closed from 2nd Feb 2019 to 11th Feb 2019. This closure is occasioned by reason of the meeting of the Board of Directors of the Company, which is scheduled to be held on 09th Feb, 2019 (As Per BSE Announcement Dated On 02/02/2019) 09th Feb 2019 Bengaluru M/s. Bombay Stock Exchange Limited Corporate Services, 25th Floor, P.J.Towers, Mumbai - 400 001. India. Security Code: 524654 Sir, Sub: Outcome of Board Meeting held on 09th Feb 2019: Board of Directors at their meeting held on 09.02.19, inter alia has transacted the following: Approval of Standalone Un-Audited Financial Results and Limited Review Report for the Quarter Ended 31st December 2018. The copy of which is enclosed in this letter and the same will be published on our companys website. This is for your information and records. Thank You, For Natural Capsules Limited. Skandan.P.Jain Company Secretary and Compliance Officer. (As Per BSE Announcement Dated On 09/02/2019)